Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. - Wikidata - wikimedia - TriplyDB

Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid.

Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid.

http://www.wikidata.org/entity/Q33745475

about

Current status of biomarker research in neurology High-throughput sequencing of immune repertoires in multiple sclerosis B Cells and Autoantibodies in Multiple Sclerosis Viral Infection of the Central Nervous System Exacerbates Interleukin-10 Receptor Deficiency-Mediated Colitis in SJL Mice Biomarkers in Multiple Sclerosis: An Up-to-Date Overview Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies The retrovirus/superantigen hypothesis of multiple sclerosis.Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination.Novel approaches for identifying target antigens of autoreactive human B and T cells Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF.Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis.Intrathecally synthesized IgG in multiple sclerosis cerebrospinal fluid recognizes identical epitopes over time.Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis.Autoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositis.Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders.B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis.Antigen microarrays identify CNS-produced autoantibodies in RRMS.IL-10 producing B cells partially restore E2-mediated protection against EAE in PD-L1 deficient mice.B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis The conundrum of iron in multiple sclerosis--time for an individualised approach.Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants Investigating the Antigen Specificity of Multiple Sclerosis Central Nervous System-Derived Immunoglobulins What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis?A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.B cell exchange across the blood-brain barrier in multiple sclerosis.Human anti-varicella-zoster virus (VZV) recombinant monoclonal antibody produced after Zostavax immunization recognizes the gH/gL complex and neutralizes VZV infection Critical role of activation induced cytidine deaminase in experimental autoimmune encephalomyelitis.Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease.Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins Cerebrospinal-fluid-derived immunoglobulin G of different multiple sclerosis patients shares mutated sequences in complementarity determining regions.Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis.Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients.In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses.Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain.

P2860

Q26744505-6B23C31D-36AA-49AC-AD82-361F07EFC95E Q26747682-0442118A-9C90-4A40-A984-BDD1593546CE Q26801386-63D6CD7E-7D2D-4128-A48A-4FE5682BA703 Q27324510-2EB05D8D-D1F3-4F8B-94A4-8E0336DFDBFD Q27496017-773766FA-A93F-4B29-A6B4-354FBA1AA8C2 Q28067334-2C39EE86-C35C-4CAB-87AB-2A080B9F8B53 Q30317136-30E48D56-2B0E-4318-A11D-DCB47FCEB662 Q30842875-2CA58405-5972-43F2-B4A4-520253FFEB08 Q33504656-8455B501-8254-436E-AE11-A80E5276D046 Q33777821-9068C3A4-B7F1-46C7-AD9F-EAD6BF4BF39B Q33834605-2A116C97-8BA6-482E-A93B-91C3F85E5A16 Q34073320-700C868F-1960-4D05-9871-E5968A4F6359 Q34251673-33B9DD90-C654-49E2-8CC0-97D7223AC68C Q34447370-E87571CD-E792-454B-9923-FD44B65D7025 Q34960518-8810A559-2C94-4507-A542-4ABB71A679BC Q35078327-33E2383F-79EB-4630-A6E3-05FED9D31AF6 Q35298764-DB0E8650-30B0-4405-ABF3-21E6F8D64864 Q35544312-388C1F4A-9970-4D90-B99A-F144F0148281 Q35613006-4DED8B74-4193-4194-A897-BBB471092C0D Q35758506-22716D36-9070-4F78-82A3-19FD4DBA8F22 Q35880717-B629A556-DEFD-4625-BE4F-D4C7D226E1B9 Q35946128-8689C6CA-13EF-485D-BDF1-F72E44AE6102 Q36104857-CE0663C6-DE50-4ED6-8033-0B4DA5C2BFE5 Q36110218-3BEC85BC-FF14-44A7-83C3-2DC369B22473 Q36304844-2085FADA-D2C0-4CF9-A5C3-43E56F5F9F11 Q36330016-87963730-868B-464A-B262-FB6D4750463F Q36396476-3C2241F9-11B2-42E1-8F13-28A004666E46 Q36455070-2B021AA2-99CF-472F-9EAE-75944686EE89 Q36498036-9BB8C286-C281-42F5-8E07-FF4FA00A75F5 Q36506762-79060321-BF58-46C1-8BC5-47F164A65E11 Q36634895-B5F8F4F2-6315-4913-BFA5-CB58162835CD Q36778684-1CEC0AD1-5244-454C-8A64-5B9F3DAE8AEE Q36887316-819645DC-0CF4-489B-BE79-D44375A621EE Q37080194-0A93B699-8029-4A9C-8399-23720B110B1E Q37102527-53940FDA-8AFB-4185-B3FA-70E9D528C095 Q37389023-72292165-399A-45F5-A141-2685C0978FC5 Q37400955-9F8D479B-672B-428C-8CEC-A8873A979BCA Q37645937-3F2372D1-159D-42D3-B6BD-00423F038919 Q37652977-9F657D2F-E177-445C-B6C0-8B1F74B6C80C Q37688795-B9BBAA9C-D504-453F-84F2-94514EEF7D31

P2860

Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid.

http://www.wikidata.org/entity/Q33745475

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Antibodies produced by clonall ...... sclerosis cerebrospinal fluid.

@ast

Antibodies produced by clonall ...... sclerosis cerebrospinal fluid.

@en

type

label

Antibodies produced by clonall ...... sclerosis cerebrospinal fluid.

@ast

Antibodies produced by clonall ...... sclerosis cerebrospinal fluid.

@en

prefLabel

Antibodies produced by clonall ...... sclerosis cerebrospinal fluid.

@ast

Antibodies produced by clonall ...... sclerosis cerebrospinal fluid.

@en

P1433

Q33745475-DF3234B7-7EDE-4AF4-AB64-7E73C36B4ABC

P1476

Q33745475-2F85C860-A393-4E60-B97B-743AFBB2CDFB

P2093

Q33745475-03BD94FD-7428-4D28-9BFA-EF71706CAAF1

Q33745475-18BECB4E-0C42-47B4-B884-519F67922B58

Q33745475-21AB8CA7-8338-4068-8795-90A0749BAD0F

Q33745475-2B58604F-1377-4E3B-B717-788D62922735

Q33745475-3250A7AA-6540-4464-BBC8-F5887915233B

Q33745475-428285B1-BFF1-47DE-879D-5532FE74E251

Q33745475-7F100729-30B2-498B-A240-67A5F833B19C

Q33745475-A9ECE238-2B23-450E-97D6-EE9C91E5B55E

Q33745475-C3850CC5-637F-4EFD-8595-D3F92967D0ED

Q33745475-C720E7B7-14D1-4372-85E9-522850D879D3

P2860

Q33745475-0EFEE5F1-D60C-4BCA-9C5B-7683313955CD

Q33745475-10AAD5B4-F475-4DF9-B2E6-E7EA1CCB1020

Q33745475-18D5F1E0-297D-4260-AADA-22561A32CDD5

Q33745475-2E5B23B2-5D2D-441C-B38F-A6C87724F264

Q33745475-33638E01-D51D-4817-AF79-37F2A1AF5383

Q33745475-362C577F-55EF-422F-A130-97C81CFF758D

Q33745475-3E5AAB4D-9615-448D-8EA6-1B313AAD5997

Q33745475-40093961-A68F-4DAE-8B04-51D2B0F2DC32

Q33745475-46C21A66-2538-4F07-9D6F-4910C382C111

Q33745475-508776A8-FD0C-4558-9196-4FA8C80A7311

P304

Q33745475-A590177C-FEF3-45A0-A139-7EDF461E8315

P31

Q33745475-B7432721-82B2-4654-8F45-459613F371D4

P356

Q33745475-EC3B02A7-2B60-466D-9029-5722D91A0756

P433

Q33745475-7F7B1CDE-6ADD-4D5A-8778-A5D03FC3DDCA

P478

Q33745475-FD1C123D-68FE-4144-B682-8B46BCFFB952

P50

Q33745475-5CFEA6D9-D57A-4F1E-9886-3B16DA6AE5DF

P577

Q33745475-BE40803F-F751-4868-B317-F4DF2FD2BA89

P5875

Q33745475-6149B0A6-6F4F-4882-BFBA-F521F7A618E2

P698

Q33745475-8D7E05B3-64FA-428E-BEA5-1D70800E7587

P921

Q33745475-1FD2E5BC-C479-4C67-A896-DD71C28B1C9E

Q33745475-C811148E-B2E3-493C-B681-5B56C0A805B4

Q33745475-D7C92479-1342-4AA8-8C9D-6430CA5BCC02

P932

Q33745475-30599E76-91FB-457D-B38C-E9A28BCBD098

P356

P1433

Annals of Neurology

P1476

Antibodies produced by clonall ...... sclerosis cerebrospinal fluid.

@en

P2093

Alanna M Ritchie

http://www.w3.org/2001/XMLSchema#string

Andrew Shearer

http://www.w3.org/2001/XMLSchema#string

Cecily DuPree

http://www.w3.org/2001/XMLSchema#string

Chiwah Lam

http://www.w3.org/2001/XMLSchema#string

Don Gilden

http://www.w3.org/2001/XMLSchema#string

Gregory P Owens

http://www.w3.org/2001/XMLSchema#string

Hans Lassmann

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Bennett

http://www.w3.org/2001/XMLSchema#string

Kevin C O'Connor

http://www.w3.org/2001/XMLSchema#string

Marius Birlea

http://www.w3.org/2001/XMLSchema#string

P2860

Environmental risk factors for multiple sclerosis. Part I: The role of infection

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event

Homogeneity of active demyelinating lesions in established multiple sclerosis

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

Varicella-zoster virus in cerebrospinal fluid at relapses of multiple sclerosis

Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies

Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?

Cloning the antibody response in humans with inflammatory CNS disease: isolation of measles virus-specific antibodies from phage display libraries of a subacute sclerosing panencephalitis brain.

Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodies

P304

639-649

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.21641

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

David A. Hafler

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26322128

http://www.w3.org/2001/XMLSchema#string

P698

19557869

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

multiple sclerosis

P932

2843543

http://www.w3.org/2001/XMLSchema#string